20311 ⎘
Medicinal preparations containing organic active ingredients; Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil Proline; Derivatives thereof, e.g. captopril
Pharmacological prophylactics against stress-induced affective disorders and their associated symptoms
#302ORAL SOLUTION OF ACE INHIBITORS
#303INHIBITORS OF JUN N-TERMINAL KINASE
#304Modified release orally administered amino acid formulations
#305Oral formulations of pyrrolidine derivatives
#306MEMBRANE ACTIVE MOLECULES
#307Pharmaceutical composition for inhibiting alpha-glucosidase
#308Enalapril formulations
#3097-dehydrocholesterol derivatives and methods using same
#310METHOD OF TREATING OR PREVENTING RAS-MEDIATED DISEASES
#311POLYNUCLEOTIDE COMPOSITIONS CONTAINING AMINO ACIDS
#312Indenyl compounds, pharmaceutical compositions, and medical uses thereof
#313METHODS AND COLLAGEN PRODUCTS FOR TISSUE REPAIR
#314METHODS AND COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF FRIEDREICH'S ATAXIA
#315Plant virus particles for delivery of antimitotic agents
#316Multi-ligand drug conjugates and uses thereof
#317Compositions and Methods for the Treatment of Diseases Related to the Renin-Angiotensin-System
#318Healthful supplements
#319Extracellular vesicles derived from osteoblastic lineage cells for therapeutic and diagnostic use
#320Methods comprising continuous administration of a GLP-1 receptor agonist and co-administration of a drug
#321Modified release orally administered amino acid formulations
#322COMPOSITIONS AND METHODS FOR AMELIORATING CACHEXIA
#323Compositions and methods that modulate vitamin D and bone mineral content in a companion animal
#324Method for diagnosis of primary hyperaldosteronism
#325AMINO ACID SUPPLEMENTATION
#326Ertugliflozin co-crystals and process for their preparation
#327AMINO ACID SUPPLEMENTATION FOR A HEALTHY MICROBIOTA ECOSYSTEM
#328THE COMPOSITIONS OF GLYCEROL AND /OR NON-TOXIC AMINO ACIDS FOR INHIBITING AND DESTROYING BIOFILM, INCLUDING RELATED METHODS
#329Sulphamoylpyrrolamide derivatives and the use thereof as medicaments for the treatment of hepatitis B
#330Compositions and methods for treating alopecia
#331Bicyclic aryl sphingosine 1-phosphate analogs
#332Sulfamoyl-arylamides and the use thereof as medicaments for the treatment of hepatitis B
#333Method for preventing lung diseases in smokers and non-smokers using antihypertensive drug
#334Egg chalaza hydrolysate, method for preparing the same and usage of the same
#335Benzimidazole inhibitors of the sodium channel
#336Compositions Methods for Treating Chronic Kidney Disease
#337PHARMACEUTICAL COMPOSITIONS WITH SYNCHRONIZED SOLUBILIZER RELEASE
#338ANTI-PCSK9 COMPOUNDS AND METHODS FOR THE TREATMENT AND/OR PREVENTION OF CARDIOVASCULAR DISEASES
#339Heterocycle analogs of CAI-1 as agonists of quorum sensing in vibrio
#340USE OF RANK/RANKL ANTAGONISTS FOR TREATING NEUROMUSCULAR DISORDERS, GENETIC MYOPATHIES AND/OR NON GENETIC MYOPATHIES AND/OR FOR REGULATING SKELETAL AND CARDIAC MUSCLE DISUSE, DISEASES AND AGING
#341THERAPEUTIC NANOPARTICLES AND METHODS THEREOF
#342Enalapril formulations
#343Method of treating or preventing Ras-mediated diseases
#344INHIBITORS OF JUN N-TERMINAL KINASE
#345Liquid formulation
#346Compositions and methods for treatment of edema
#347Compositions and methods for managing digestive disorders and a healthy microbiome
#348Inhibitors of the renal outer medullary potassium channel
#349Nutritional composition useful in the treatment of IBD patients
#350PROMOTION OF HEALING OF INTESTINAL MUCOSA USING PROLINE, SERINE AND THREONINE
#351NOVEL COMPOUND AND ANTIVIRAL AGENT CONTAINING SAME AS ACTIVE INGREDIENT
#352Aging inhibitor
#353Preventive or therapeutic agent for age-related macular degeneration
#354Methods and compositions for enhancing or maintaining fertility
#355Aminoacid-based composition for fibroelastin recovery in dermal connective tissues
#356Compounds and Compositions for Cognition-Enhancement, Methods of Making, and Methods of Treating
#357Paroxysmal extreme pain disorder treatment
#358Erythromelalgia treatment
#3592-aminoethanol dihydrogen phosphate-based dietary supplement and synthesis process thereof
#360INHIBITORS OF HEPATITIS C VIRUS
#361Novel Small Fibre Neuropathy Treatment
#362INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL
#363INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL
#364Enalapril formulations
#365Local administration-type pharmaceutical for improving dysphagia
#366Hepatitis B antiviral agents
#367Bicyclic aryl sphingosine 1-phosphate analogs
#368Proline or proline derivatives for the treatment of dementia
#369Heterocyclic compound
#370Ionic cocrystal of lithium, lispro, for the treatment of fragile X syndrome
#371DELIVERY MOLECULES FOR THERAPEUTICS
#372Methods and compositions for treating pain
#373Compositions and methods for treating alopecia
#374Water dispersible mini-tablets comprising Enalapril for treatment of hypertension in a pediatric population and method of preparation thereof
#375METHODS FOR TREATING MULTIPLE SCLEROSIS
#376Compositions for providing agents that degrade in water
#377Method
#378D-SERINE TRANSPORTER INHIBITORS AS PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS
#379Therapeutic combination and methods of treatment with a DLL4 antagonist and an anti-hypertensive agent
#380Pharmaceutical composition containing verbenone derivative for treating or preventing neurodegenerative disease
#381Compositions and methods for treating fibromyalgia
#382THERAPEUTIC NANOPARTICLES AND METHODS THEREOF
#383Inhibitors of Jun N-terminal kinase
#384COMPOSITIONS CONTAINING NITRIC OXIDE AMINO ACID ESTERS AND METHODS FOR IMPROVING SEXUAL PERFORMANCE
#385Thiol and disulfide-containing agents for increasing meibomian gland lipid secretion
#386Fortifier
#387Metakaryocidal treatments
#388Treatment of central nervous system disorders by intranasal administration of immunoglobulin G
#3897-dehydrocholesterol derivatives and methods using same
#390Treatment of Multidrug-Resistant Nephrotic Syndrome (MDR-NS) in Children
#391GLYCOAMINO ACID AND USE THEREOF
#392COMPOSITION INVOLVED IN REGULATING ENERGY CYCLE, INFLAMMATION AND INSULIN RESISTANCE DYSFUNCTIONS, AND USE THEREOF PARTICULARLY IN CARDIOMETABOLIC DISEASES
#393Treatment of metabolic disorders in canine animals
#394OLIVAMINE-INDUCED IMPROVEMENT IN ENDOTHELIAL CELLS VIABILITY AND FUNCTION
#395METHODS FOR THE TREATMENT AND PREVENTION OF RENAL DISORDERS AND FATTY LIVER DISORDERS
#396Methods and Diets to Protect Against Chemotoxicity and Age Related Illnesses
#397Compositions and methods for the treatment of diseases related to the renin-angiotensin-system
#398Inhibitors of the renal outer medullary potassim channel
#399Cyclic-GluR6 analogs, methods of treatment and use
#400Dietary supplement containing alkaline electrolyte buffers
#401Method for diagnosis of primary hyperaldosteronism
#402Joint care composition
#403Polynucleotide compositions containing amino acids
#404Control of Blood Vessel Physiology To Treat Skin Disorders
#405Intradialytic parenteral nutrition compositions
#406Methods for overcoming glucocorticoid resistance and for determining glucocorticoid resistance potential in cancer
#407Cosmetic compositions
#408Methods and products for tissue repair
#409Heterocycle analogs of CAI-1 as agonists of quorum sensing in vibrio
#410Method of selectively inhibiting Ras-mediated tumor growth in humans
#411Indenyl compounds, pharmaceutical compositions, and medical uses thereof
#412ADDITIVES AND SUPPLEMENTS
#413Laser assisted wound healing protocol and system
#414Nutritional composition for improving brain function in phenylketonuria
#415Methods for the regulation of matrix metalloproteinase expression
#416Cooperative Medication Combination Systems
#417SYNBIOTIC COMPOSITION FOR TREATMENT OF INFECTIONS IN ALLERGIC PATIENTS
#418Pharmaceutical for improving dysphagia
#419Amino acid supplementation for a healthy microbiota ecosystem
#420CONJUGATES OF POLYUNSATURATED FATTY ACIDS AND AMINE-CONTAINING COMPOUNDS AND USES THEREOF
#421Methods and compositions for regulating SRCA2A expression levels in myocardial infarction
#422Sulphamoylpyrrolamide derivatives and the use thereof as medicaments for the treatment of hepatitis B
#423Methods to inhibit infection during wound healing with topical compositions including amino acids
#424Method and Composition for Treating Heart Failure
#425Combination therapy with nitrated lipids and inhibitors of the renin-angiotensin-aldosterone system
#426Biological Basis Of Adult Wellness
#427Selective androgen receptor modulators (SARMS) and uses thereof
#428Inhibitors of the renal outer medullary potassium channel
#429AGENTS AND DEVICES FOR AFFECTING NERVE FUNCTION
#430Glycyrrhetinimidyl hydroxyproline alkyl esters and protected derivatives thereof
#431Inhibitors of the renal outer medullary potassium channel
#432Combinations of Oral Medicaments Bonded by a Wrapping
#433Anti-PCSK9 compounds and methods for the treatment and/or prevention of cardiovascular diseases
#434Acylguanidines for treating osteoarthritis
#435Pyrrole derivatives as alpha 7 NACHR modulators
#436SELECTIVE INHIBITORS OF HISTONE DEACTYLASE
#437Combinations of SGLT 2 inhibitors and antihypertensive drugs
#438Nutritional Composition for Gastrostomy-Tube Patients
#439Combination of (3S,3S′) 4,4′-disulfanediylbis(3-aminobutane 1-sulfonic acid) and a second antihypertensive agent
#440Oral forms of a phosphonic acid derivative
#441Inhibitors of the renal outer medullary potassium channel
#442Inhalation-type pharmaceutical composition for the treatment of hypertension and preparation method thereof
#443Local administration-type pharmaceutical for improving dysphagia
#444TREATING POLYCYSTIC KIDNEY DISEASE WITH HSP90 INHIBITORY COMPOUNDS
#445SULFAMOYL-ARYLAMIDES AND THE USE THEREOF AS MEDICAMENTS FOR THE TREATMENT OF HEPATITIS B
#446Sulfamoyl-arylamides and the use thereof as medicaments for the treatment of hepatitis B
#447ENALAPRIL COMPOSITIONS
#448ORAL FORMULATIONS OF ANGIOTENSIN
#449Proline sulfonamide derivatives as orexin receptor antagonists
#450AGENTS, METHODS, AND DEVICES FOR AFFECTING NERVE FUNCTION
#451Nitric Oxide Amino Acid Esters for Improving Vascular Circulation, and Prophylaxis or Treatment of a Condition Associated with Impaired Blood Circulation
#452Treatment of rett syndrome using glycyl-L-2-methylprolyl-L-glutamic acid
#453Gluten-related disorders
#454Angiotensin converting enzyme inhibitors for treating optic neuropathy or congenital optic atrophy
#455PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF VISUAL SYSTEM DISORDERS
#456Oral formulations of pyrrolidine derivatives
#457Methods and compositions for treating pain
#458Pharmaceutical composition containing verbenone derivative for treating or preventing neurodegenerative disease
#4593,5,N-trihydroxy-alkanamide and derivatives: method for making same and use thereof
#460Liquid formulation
#461Nanoparticle delivery vehicle for S-nitroso-N-acetyl cysteine and uses thereof
#462ALLOSTERIC CHAPERONES AND USES THEREOF
#463Methods for treating HCV
#464Dietary Compositions and Methods for Protection Against Chemotherapy, Radiotherapy, Oxidative Stress, and Aging
#465AGENTS AND DEVICES FOR AFFECTING NERVE FUNCTION
#466METHOD FOR ADMINISTRATION
#467Fused ring compound for use as mineralocorticoid receptor antagonist
#468Therapeutic combination and methods of treatment with a DLL4 antagonist and an anti-hypertensive agent
#469Compounds and Compositions for Cognition-Enhancement, Methods of Making, and Methods of Treating
#470Combination for the treatment of radiation- or chemotherapy-induced mucositis
#471Biological Basis of Adult Wellness
#472Compositions prepared from poultry and methods of their use
#473Crystalline forms of zofenopril calcium
#474Methods for improved wound closure employing olivamine and endothelial cells
#475Aprepitant L-proline solvates—compositions and cocrystals
#476Pharmaceutical composition for treating diabetes
#477Inhibitors of the renal outer medullary potassium channel
#478Amino acid supplementation for a healthy microbiota ecosystem
#479Nutritional supplements
#480INHIBITION OF THE RENIN-ANGIOTENSIN SYSTEM FOR THE TREATMENT OF RENAL, VASCULAR AND CARTILAGE PATHOLOGY
#481Methods and compositions for treating pain
#482Use of RANK/RANKL antagonists for treating muscular dystrophy
#483Esters of N-acyl derivatives of amino acids and diols, method for preparing same, and use thereof in cosmetics and as a drug
#484COMPOUND CAPABLE OF BINDING S1P RECEPTOR AND PHARMACEUTICAL USE THEREOF
#485Cosmetic compositions
#486Combination therapy with nitrated lipids and inhibitors of the renin-angiotensin-aldosterone system
#487Compositions for increasing human growth hormone levels
#488Treatment of central nervous system disorders by intranasal administration of immunoglobulin G
#489Compositions and methods of treating gliomas
#490Methods and diets for lowering glucose and/or IGF-1 levels
#491D-serine transporter inhibitors as pharmaceutical compositions for the treatment of visual system disorders
#492PRODUCT FOR PARENTERAL NUTRITION OF OBESE INTENSIVE-CARE PATIENTS
#493Methods of facilitating neural cell survival using non-peptide and peptide BDNF neurotrophin mimetics
#494D-SERINE TRANSPORTER INHIBITORS AS PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS
#495SUPPRESSION OF TOXIN PRODUCTION OF CLOSTRIDIUM DIFFICLE
#496Methods of regulating glucose metabolism, and reagents related thereto
#497Medicinal skin protection composition with an active ingredient combination which improves the skin barrier
#498Biaryl derivatives as nAChR modulators
#499Treatment of fragile X syndrome using glycyl-L-2-methylprolyl-L-glutamate
#500Eosinophil peroxidase compositions and methods of their use
#501Enalapril compositions
#502AMINO ACID COMPOSITION
#503Methods for increasing endurance and fat metabolism in humans
#504METHODS FOR IMPROVING LINEAR GROWTH RESPONSE IN CHILDREN
#505Methods and compositions for increasing growth hormones
#506Compositions for increasing human growth hormone levels
#507Methods for improving thyroid function in a subject
#508Methods for increasing human growth hormone levels
#509METHODS FOR DRUG SCREEN USING ZEBRAFISH MODEL AND THE COMPOUNDS SCREENED THEREFROM
#510PHARMACEUTICAL COMPOSITION FOR TREATING AND PREVENTING DISEASES RELATED TO JOINT AND CONNECTIVE TISSUE
#511Method of destroying bacterial biofilm using sterile intravenous or intracavernous glycerin
#512Methods of improving cognitive function
#513COMPOSITION FOR TREATING DERMATITIS AND ICHTHYOSIS, AND METHOD FOR TREATING DERMATITIS AND ICHTHYOSIS
#514Combination for the treatment of osteoarthritis
#515COMPOSITIONS FOR IMPROVING MENTAL PERFORMANCE
#516Fused ring compound for use as mineralocorticoid receptor antagonist
#517Injectable amino-acid composition
#518Methods and products for tissue repair
#519Methods for improved wound closure employing olivamine and human umbilical vein endothelial cells
#520Method for promoting synthesis of tissue collagen
#521Formulation for the prevention of cardiovascular disease
#522MODULATION OF AMINO ACID METABOLISM IN THE HYPOTHALAMUS
#523Compositions and methods of treatment of cancer
#524Methods of treating heart failure
#525SKIN CARE COMPOSITIONS
#526Pharmaceutical composition for treating coagulation disorder hemorrhage and method using the same
#527Therapeutic use of agonists or antagonists of bradykinin receptor 1 or 2, for modulation collateral blood vessel growth
#528STABLE LIQUID OILY READY-TO-USE FORMULATIONS, PREPARATION THEREOF AND USE THEREOF
#529Compositions and methods for treating nephropathy
#530Inhibitors of Jun N-terminal kinase
#531METHODS AND COMPOSITIONS FOR TREATING BIOFILMS
#532METHODS AND COATINGS FOR TREATING BIOFILMS
#533Suppression of cancer growth and metastasis using nordihydroguaiaretic acid derivatives with 7-hydroxystaurosporine
#534PHARMACEUTICAL COMPOSITIONS WITH SYNCHRONIZED SOLUBILIZER RELEASE
#535COMBINATION FOR THE TREATMENT OF RADIATION- OR CHEMOTHERAPY-INDUCED MUCOSITIS
#536KALLIKREIN 7 MODULATORS
#537Product for parenteral nutrition of obese intensive-care patients
#538New class of therapeutics that enhance small molecule diffusion
#539Fasudil in combination therapies for the treatment of pulmonary arterial hypertension
#540Method for Reducing Levels of Disease Associated Proteins
#541D-serine transporter inhibitors as pharmaceutical compositions for the treatment of central nervous system disorders
#542Pemirolast for the Treatment of Systemic Low Grade Inflammation
#543COMBINATION FOR THE TREATMENT OF OSTEOARTHRITIS
#544DOSING REGIMENS AND METHODS FOR TREATING OR PREVENTING HEPATOCELLULAR CARCINOMA
#545D-serine transporter inhibitors as pharmaceutical compositions for the treatment of visual system disorders
#546Compositions, Kits, and Methods for the Treatment of Conditions Associated with Elevated Cholesterol Levels
#547ACTIVITY GENERATING DELIVERY MOLECULES
#548NUTRITIVE COMPOSITIONS AND METHODS OF USING SAME
#549Ankle and foot bone growth compositions and methods
#550Methods of treatment with DLL4 antagonists and an anti-hypertensive agent
#551Drug Combinations and Uses in Treating a Coughing Condition
#552Amino acid composition with improved dispersibility
#553Composition comprising benzoic acid in combination with organic acid preservatives as active ingredients and the use thereof
#5541-methylnicotinaide derivatives and formulations of treatment of lipoprotein abnormalities
#555Methods for Treating Autoimmune Disorders, and Reagents Related Thereto
#556Cyclic-GluR6 analogs, methods of treatment and use
#557COSMETIC AND PHARMACEUTICAL COMPOSITIONS COMPRISING ACE INHIBITORS AND/OR ANGIOTENSIN II RECEPTOR ANTAGONISTS
#558PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION
#559TREATMENT OF METABOLIC DISORDERS
#560SKIN COMPOSITION COMPRISING AN EXFOLIATE, A BRIGHTENER AND A COLLAGEN BOOSTER, AND METHOD OF USING THE SAME
#561Bicyclic aryl sphingosine 1-phosphate analogs
#562Oral forms of a phosphonic acid derivative
#563Laminin-332 product on stimulating composition
#564Substituted amide compound
#565Use of inhibitors of the renin-angiotensin system
#566Compositions for Reducing the Incidence of Drug Induced Arrhythmia
#567Method of regulating glucose metabolism, and reagents related thereto
#568Composition for alleviating ultraviolet radiation-induced damage
#569SKIN-WHITENING AGENT AND COSMETIC METHOD FOR WHITENING SKIN
#570Treatment for dyslipidemia
#571Novel Metabolic Disease Therapy
#572FIXED DOSE DRUG COMBINATION FORMULATIONS
#573Mannitol and/or Proline for Prevention and Treatment of Ageing Related Symptoms
#574Elastase inhibitor
#575USE OF SUBSTITUTED CYANOPYRROLIDINES AND COMBINATION PREPARATIONS CONTAINING THEM FOR TREATING HYPERLIPIDEMIA AND ASSOCIATED DISEASES
#576Selective androgen receptor modulators (SARMs) and uses thereof
#577HYDROXYPROLINE COMPOSITIONS AND USES THEREOF
#578Method and composition for treating heart failure
#579Amino acid compositions
#580ACETYLATED AMINO ACIDS AS ANTI-PLATELET AGENTS, NUTRITIONAL AND VITAMIN SUPPLEMENTS
#581METHODS FOR TREATING DISORDERS ASSOCIATED WITH HYPERLIPIDEMIA IN A MAMMAL
#582METHODS FOR TREATING DISORDERS ASSOCIATED WITH HYPERLIPIDEMIA IN A MAMMAL
#583Acetylated amino acids as anti-platelet agents, nutritional and vitamin supplements
#584Inhalable Formulations For Treating Pulmonary Hypertension And Methods Of Using Same
#585Compounds and compositions for cognition-enhancement, methods of making, and methods of treating
#586COMBINATION OF (A) A DNA TOPOSOMERASE INHIBITOR AND (B) AN IAP INHIBITOR
#587COMBINATION THERAPIES FOR TREATMENT OF HYPERTENSION AND COMPLICATIONS IN PATIENTS WITH DIABETES OR METABOLIC SYNDROME
#588USE OF REMOTE ISCHEMIC CONDITIONING TO IMPROVE OUTCOME AFTER MYOCARDIAL INFARCTION
#589NUTRITIONAL COMPOSITION FOR WOUND HEALING
#590Treatment of dissection, aneurysm, and atherosclerosis using granzyme B inhibitors
#5915-membered heterocyclic compound
#592Methods and Compositions for Treatment of Prostate Intraepithelial Neoplasia
#593Method of regulating glucose metabolism, and reagents related thereto
#594FASUDIL IN COMBINATION THERAPIES FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION
#595Combinations of SAP depleting agents and anti-SAP antibodies
#596Treating vascular events with statins by inhibiting PAR-1 and PAR-4
#597PHOTO-PROTECTIVE DERMATOLOGICAL FORMULATIONS
#598COMPOUNDS FOR THE TREATMENT OF PERIPHERAL NEUROPATHIES
#599Pharmaceutical Compositions of Atorvastatin
#600Aniline analogs as glycogen synthase activators